Operating Income: The income after operating expenses.
10x Genomics (TXG) had Operating Income of $-19.55M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$151.04M |
|
$-17.93M |
|
$38.54M |
|
$112.50M |
|
$170.59M |
|
|
Operating Income |
$-19.55M |
$0.91M |
|
$-18.64M |
|
$-18.64M |
|
$-17.93M |
|
$-17.93M |
|
$-17.93M |
|
$-17.93M |
|
$-19.55M |
|
$-5.92M |
|
129.98M |
|
129.98M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$674.67M |
|
$215.32M |
|
$355.39M |
|
$1.03B |
|
$118.51M |
|
-- |
|
$86.01M |
|
$204.52M |
|
$825.55M |
|
$757.47M |
|
$825.55M |
|
130.28M |
|
| Cash Flow Statement Financials | |
$43.09M |
|
$-9.05M |
|
$-5.40M |
|
$473.97M |
|
$502.51M |
|
$28.55M |
|
$48.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
74.48% |
|
-12.95% |
|
-12.95% |
|
-- |
|
-12.34% |
|
-11.87% |
|
$39.91M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.73 |
|
2.98 |
|
30.17 |
|
-2.17% |
|
-2.37% |
|
-1.74% |
|
-2.17% |
|
$6.34 |
|
$0.31 |
|
$0.33 |
|